Atlas Trials

Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome

Clinical trial NCT00732680 · TERMINATED

Trial details

NCT number
NCT00732680
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Empty Nose SyndromeAtrophic Rhinitis
Start date
2008-12-01
Primary completion
2009-11-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.